Teva Records $646M Expense For Legal Settlements, Including Opioid Litigation
PETACH TIKVA, Israel — Drug manufacturer Teva Pharmaceutical Industries Ltd. on Aug. 7 told stockholders that in the second quarter, it recorded an expense of $646 million in legal settlements and...To view the full article, register now.
Already a subscriber? Click here to view full article